Can Prasol Chemicals IPO deliver long-term growth for high-risk investors?
Prasol Chemicals plans an IPO to raise funds for debt repayment and expansion. The company's revenue and profits have shown significant growth in recent years. Its product portfolio includes acetone and phosphorus-based specialty chemicals for various industries. Capacity utilization at one plant improved, though it remains relatively low. Investors with a high-risk appetite may consider applying…
Prasol Chemicals, a specialty chemicals company, plans to raise ₹80 crore through a fresh issue and ₹420 crore through an offer for sale, with the promoter group's stake falling to 77.5% from 89.2%. The company, operating in Maharashtra, manufactures over 150 specialty chemicals, with 40% of its revenue coming from a single product category.
Prasol Chemicals exports to 69 countries and derives over a quarter of its revenue from international markets. Its top 10 customers account for 23.7% of revenue, while its top 10 suppliers account for nearly 69% of raw material purchases. The company's capacity utilization at its Mahad plant improved to 44.1% in FY26 from 12.7% in FY24 but remains relatively low.
With an 18.6% annual growth in revenue from operations and a 114.1% annual growth in net profit between FY24 and FY26, the company demonstrates solid financial performance. However, investors with a high-risk appetite may find this IPO appealing, given the company's P/E multiple of 48, which is significantly higher than its peers' range of 27-197.
Brief written by urgent.news from The Economic Times - Top News's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
